Patients with Fukuyama-type congenital muscular dystrophy sometimes experience transient exacerbations of muscle weakness. We took care of a 9-year-old boy with Fukuyama-type congenital muscular dystrophy who presented with acute respiratory failure and decreased exercise ability with marked elevation of serum creatine kinase indicating rhabdomyolysis. At that time, his younger sister suffered from erythema infectiosum. Although he had no particular symptoms, he was tested and proven to have acute human parvovirus B19 infection based on detection of anti-B19 IgM and parvovirus B19 DNA in his serum. His acute rhabdomyolysis was possibly triggered by human parvovirus B19 infection.
FukuyamaYKawazuwaMHarunaH. A peculiar form of congenital progressive muscular dystrophy. Report of fifteen cases. Paediatr Univ Tokyo. 1960;4:5–8.
3.
KnollALouwenFKochanowskiB, et al.Parvovirus B19 infection in pregnancy: quantitative viral DNA analysis using a kinetic fluorescence detection system (TaqMan PCR). J Med Virol. 2002;67:259–266.
4.
OsawaMSumidaSSuzukiN, et al.Fukuyama type congenital progressive muscular dystrophy. In: FukuyamaYOsawaMSaitoK, eds. Developments in Neurology 43, Congenital Muscular Dystrophies. Amsterdam: Elsevier; 1997, 31–68.
5.
ObataRYasumiYSuzukiANakajimaYSatoS. Rhabdomyolysis in association with Duchenne's muscular dystrophy. Can J Anaesth. 1999;46:564–566.
6.
ShojiTNishikawaYSaitoNHayashiTTogawaMOkadaNTsubakiharaY. A case of Becker muscular dystrophy and massive myoglobinuria with minimal renal manifestations. Nephrol Dial Transplant. 1998;13:759–760.
7.
TanakaTTakadaTTakagiDTakeyamaNKitazawaY. Acute renal failure due to rhabdomyolysis associated with echovirus 9 infection: a case report and review of literature. Jpn J Med. 1989;28:237–242.
8.
FodiliFvan BommelEF. Severe rhabdomyolysis and acute renal failure following recent Coxsackie B virus infection. Neth J Med. 2003;61:177–179.
LeeKYRhimJWKangJH. Hyperactive immune cells (T cells) may be responsible for acute lung injury in influenza virus infections: a need for early immune-modulators for severe cases. Med Hypotheses. 2011;76:64–69.
12.
YoungNSBrownKE. Parvovirus B19. N Engl J Med. 2004;350:586–597.
13.
KishoreJSinghJ. Detection of parvovirus B19 in a case of erythema infectiosum with myositis. Indian Pediatr. 2006;43:814–817.
14.
BeghettiMGervaixAHaenggeliCABernerMRimensbergerPC. Myocarditis associated with parvovirus B19 infection in two siblings with merosin-deficient congenital muscular dystrophy. Eur J Pediatr. 2000;159:135–136.
15.
OsawaMAraiYIkenakaH, et al.Fukuyama type congenital progressive muscular dystrophy. Acta Paediatr Jpn. 1991;33:261–269.
